La maladie de Parkinson en France (serveur d'exploration) - Merge (PascalFrancis)

Index « FA11s1.i » - entrée « RUBERG (M.) »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
ROZENBERG (Sylvie) < RUBERG (M.) < RUBERG (Merle)  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 25.
[0-20] [0 - 20][0 - 25][20-24][20-40]
Ident.Authors (with country if any)Title
000041 (2000) G. Orieux ; C. Francois ; J. Feger ; J. Yelnik ; M. Vila ; M. Ruberg ; Y. Agid ; E. C. HirschMetabolic activity of excitatory parafascicular and pedunculopontine inputs to the subthalamic nucleus in a rat model of Parkinson's disease
000127 (2000) M. G. Murer ; G. Dziewczapolski ; P. Salin ; M. Vila ; K. Y. Tseng ; M. Ruberg ; M. Rubinstein ; M. A. Kelly ; D. K. Grandy ; M. J. Low ; E. Hirsch ; R. Raisman-Vozari ; O. GershanikThe indirect basal ganglia pathway in dopamine D2 receptor-deficient mice
000199 (2000) M. RubergMaladie de Parkinson: Vers un mécanisme de mort neuronale
000554 (2003) A. Lannuzel ; P. P. Michel ; G. U. Höglinger ; P. Champy ; A. Jousset ; F. Medja ; A. Lombes ; F. Darios ; C. Gleye ; A. Laurens ; R. Hocquemiller ; E. C. Hirsch ; M. RubergThe mitochondrial complex I inhibitor annonacin is toxic to mesencephalic dopaminergic neurons by impairment of energy metabolism
000966 (2007) Annie Lannuzel ; G. U. Höglinger ; S. Verhaeghe ; L. Gire ; S. Belson ; M. Escobar-Khondiker ; P. Poullain ; W. H. Oertel ; E. C. Hirsch ; B. Dubois ; M. RubergAtypical parkinsonism in Guadeloupe : a common risk factor for two closely related phenotypes?
001290 (1984) B. Bokobza ; M. Ruberg ; B. Scatton ; F. Javoy-Agid ; Y. Agid[3H]spiperone binding, dopamine and HVA concentrations in Parkinson's disease and supranuclear palsy
001297 (1984) R. Cash ; M. Ruberg ; R. Raisman ; Y. AgidAdrenergic receptors in Parkinson's disease
001333 (1987) M. Ruberg ; A. Villageois ; A.-M. Bonnet ; B. Pillon ; F. Rieger ; Y. AgidAcetylcholinesterase and butyrylcholinesterase activity in the cerebrospinal fluid of patients with neurodegenerative diseases involving cholinergic systems
001375 (1988) E. Hirsch ; M. Ruberg ; M.-M. Portier ; M. Dardenne ; Y. AgidCharacterization of two antigens in parkinsonian Lewy bodies
001407 (1988) L. Pierot ; C. Desnos ; J. Blin ; R. Raisman ; D. Scherman ; F. Javoy-Agid ; M. Ruberg ; Y. AgidD1 and D2-type dopamine receptors in patients with Parkinson's disease and progressive supranuclear palsy
001429 (1990) M. Ruberg ; W. Mayo ; A. Brice ; C. Duyckaerts ; J. J. Hauw ; H. Simon ; M. Lemoal ; Y. AgidCholine acetyltransferase activity and [3H]vesamicol binding in the temporal cortex of patients with Alzheimer's disease, Parkinson's disease, and rats with basal forebrain lesions
001433 (1990) D. T. Dexter ; A. Carayon ; M. Vidailhet ; M. Ruberg ; F. Agid ; Y. Agid ; A. J. Lees ; F. R. Wells ; P. Jenner ; C. D. MarsdenDecreased ferritin levels in brain in Parkinson's disease
001633 (1993) M. T. Herrero ; E. C. Hirsch ; A. Kastner ; M. Ruberg ; M. R. Luquin ; J. Laguna ; F. Javoy-Agid ; J. A. Obeso ; Y. AgidDoes neuromelanin contribute to the vulnerability of catecholaminergic neurons in monkeys intoxicated with MPTP ?
001685 (1993) Y. Agid ; M. Ruberg ; F. Javoy-Agid ; E. Hirsch ; R. Raisman-Vozari ; S. Vyas ; B. Faucheux ; P. Michel ; A. Kastner ; V. Blanchard ; P. Damier ; J. Villares ; PING ZHANGAre dopaminergic neurons selectively vulnerable to Parkinson's disease ?
001742 (1995) M. Ruberg ; D. Scherman ; F. Javoy-Agid ; Y. AgidDopamine denervation, age on onset, and Parkinson's disease
001815 (1996) B. Brugg ; P. P. Michel ; Y. Agid ; M. RubergCeramide induces apoptosis in cultured mesencephalic neurons
001830 (1996) M. Vila ; M. T. Herrero ; R. Levy ; B. Faucheux ; M. Ruberg ; J. Guillen ; M. R. Luquin ; J. Guridi ; F. Javoy-Agid ; Y. Agid ; J. A. Obeso ; E. C. HirschConsequences of nigrostriatal denervation on the γ-aminobutyric acidic neurons of substantia nigra pars reticulata and superior colliculus in parkinsonian syndromes
001866 (1996) J. Guridi ; M. T. Herrero ; M. R. Luquin ; J. Guillen ; M. Ruberg ; J. Laguna ; M. Vila ; F. Javoy-Agid ; Y. Agid ; E. Hirsch ; J. A. ObesoSubthalamotomy in parkinsonian monkeys : Behavioural and biochemical analysis
001876 (1997) R. Levy ; L.-N. Hazrati ; M.-T. Herrero ; M. Vila ; O.-K. Hassani ; M. Mouroux ; M. Ruberg ; H. Asensi ; Y. Agid ; J. Feger ; J. A. Obeso ; A. Parent ; E. C. HirschRe-evaluation of the functional anatomy of the basal ganglia in normal and Parkinsonian states
001906 (1997) M. Ruberg ; B. Brugg ; A. Prigent ; E. Hirsch ; A. Brice ; Y. AgidIs differential regulation of mitochondrial transcripts in Parkinson's disease related to apoptosis?
001966 (1997) P. P. Michel ; M. Ruberg ; Y. AgidRescue of mesencephalic dopamine neurons by anticancer drug cytosine arabinoside

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/PascalFrancis/Merge
HfdIndexSelect -h $EXPLOR_AREA/Data/PascalFrancis/Merge/FA11s1.i -k "RUBERG (M.)" 
HfdIndexSelect -h $EXPLOR_AREA/Data/PascalFrancis/Merge/FA11s1.i  \
                -Sk "RUBERG (M.)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PascalFrancis/Merge/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    PascalFrancis
   |étape=   Merge
   |type=    indexItem
   |index=    FA11s1.i
   |clé=    RUBERG (M.)
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024